GI/endoscopy company stock report – March 6, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for March 2 to March 6.

Advertisement

•    AbbVie: $56.26 (USD) per share (down 1.07 percent)
•    Boston Scientific: $16.52 (USD) per share (down 2.65 percent)  
•    FUJIFILM Holdings: 4,106.50 (JPY) per share (up 0.77 percent)
•    Olympus: 4,415 per share (JPY) (up 5.75 percent)
•    Salix Pharmaceuticals: $157.55 (USD) per share (up 0.7 percent)

More articles on gastroenterology:
GI physician leader to know: Dr. Atilla Ertan of UT Health Science Center
EndoChoice raises $57M in equity financing
FDA addresses lack of 510(k) clearance for scopes tied to ‘superbug’ infections

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.